James Park is the Senior Vice President responsible for the Business Development Center of the Samsung BioLogics. Prior to joining SBL in 2015, Mr. Park held technical and operational positions in biopharmaceutical companies in the US. From 2004-2015, Mr. Park participated, led, and directed CMC due diligence on assets ranging from pre-clinical to commercial products and managed BD activities including Licensing, Outsourcing and M&A at Bristol-Myers Squibb. Mr. Park holds a BS in Chemical Engineering from University of California, Davis and an MS in Industrial Engineering & Operations Research from Columbia University.